+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Meyler's Side Effects of Psychiatric Drugs

  • ID: 1768125
  • Book
  • November 2008
  • Region: Global
  • 512 Pages
  • Elsevier Science and Technology
1 of 3
Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician.

The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs.

The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler's Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.

This volume is critical for any health professional involved in the administration of psychiatric mediations.

- Surpasses the Physician's Desk Reference © by including clinical case studies and independent expert analysis

- Complete index of drug names

- Most complete cross referencing of drug-drug interactions available

- Extensive references to primary and secondary literature

- Also includes information on adverse effects in pregnancy

The book is divided into six sections:

- Antidepressants - A general introduction to their adverse effects, followed by monographs on individual drugs and groups of drugs (including lithium)

- Neuroleptic drugs - A general introduction to their adverse effects, followed by monographs on individual drugs

- Hypnosedatives - A general introduction to their adverse effects, followed by monographs on individual drugs

- Drugs of abuse

- Drugs used to treat Alzheimer's disease

- Psychological and psychiatric adverse effects of non-psychoactive drugs

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Note: Product cover images may vary from those shown
2 of 3
Preface

Antidepressants

Tricyclic Antidepressants

Selective Serotonin Re-uptake Inhibitors (SSRIS)

Monoamine Oxidase Inhibitors

Other Antidepressants

Lithium

Neuroleptic Drugs

Hypnosedatives

Benzodiazepines

Non-benzodiazepine Hypnosedatives

Drugs of Abuse

Amphetamines

Cannabinoids

Cocaine

Dexamfetamine

Diamorphine (Heroin)

Dimethyltryptamine

Gammahydroxybutyrate

Khat

Lysergide

Mescaline

Metamfetamine

Methadone

Methylenedioxymetamfetamine (MDMA, Ecstasy)

Organic Solvents

Phencyclidine

Psilocybin

Drugs Used in Alzheimer's Disease 629

Psychological and Psychiatric Adverse Effects of Non-psychoactive Drugs

Index of Drug Names

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Note: Product cover images may vary from those shown
Adroll
adroll